| Patient | Martin Luther |
|---|---|
| Date of birth | 1483-11-19 |
| Identifiers | MRN HR-RE004-SYN-TD; SSN (made up) 000-04-3892 |
| Document date | 2026-11-01 |
| Author | Ottilie Brandt-Mensah, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
New patient visit for attacks of vertigo with left-ear tinnitus and muffled hearing, and low mood: history, neurological and ear examination, blood and urine tests, depression and safety screening, and an otology referral. Concerns: He is frightened of another attack, especially while preaching or teaching, and of losing the hearing in his left ear; He has felt low and abandoned for weeks and wonders whether the attacks are a spiritual trial rather than an illness; He remembers the pain of the stone last year and wants to avoid another. [S]
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Meclizine 25 mg tablet, one by mouth up to every 8 hours during a severe vertigo attack only, for no more than 3 days at a time | every 8 hours as needed during a severe attack, at most 3 days at a time | Oral route | 1527-07-28 | active | S |
| Naproxen 500 mg tablet, one by mouth twice daily with food for up to 7 days for stone pain | twice daily with food for up to 7 days | Oral route | 1527-08-25 to 1527-09-01 | completed | S |
| Tamsulosin 0.4 mg capsule, one by mouth daily for up to 4 weeks or until the stone passes | once daily until the stone passes | Oral route | 1527-08-25 to 1527-09-03 | completed | S |
| Hydrochlorothiazide 25 mg tablet, one by mouth each morning | once daily in the morning | Oral route | 1527-08-11 | active | S |
| Sertraline 25 mg tablet, one by mouth each morning for one week | once daily in the morning | Oral route | 1527-08-11 to 1527-08-18 | completed | S |
| Sertraline 50 mg tablet, one by mouth each morning | once daily in the morning | Oral route | 1527-08-18 | active | S |
| Procedure | Dates | Status | Evidence |
|---|---|---|---|
| Low-dose non-contrast CT of the kidneys, ureters and bladder | 1527-08-25 to 1527-08-25 | completed | S |
| Advance care planning conversation, about 16 minutes | 1527-09-08 to 1527-09-08 | completed | S |
| Pure-tone and speech audiometry with tympanometry | 1527-08-11 to 1527-08-11 | completed | S |
| MRI of the internal auditory canals with gadolinium | 1527-09-22 to 1527-09-22 | completed | S |
| Renal and bladder ultrasound | 1527-09-22 to 1527-09-22 | completed | S |
| Repeat pure-tone and speech audiometry | 1527-10-27 to 1527-10-27 | completed | S |
| Date | Vaccine | Status | Evidence |
|---|---|---|---|
| 1527-09-08 | Tdap vaccine | completed | S |
| 1527-09-08 | Influenza vaccine, inactivated, trivalent, preservative-free | completed | S |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| his twenties | Recurrent spiritual crises with anxiety, fear and a deeply troubled conscience since his years as a monk in his twenties, which he called Anfechtungen | D (CLM-0003) |
| the past four years | Headaches with noises in the ears since his late twenties, and headaches with faint spells and dizziness reported by his physician for about four years | D (CLM-0007) |
| May 1521 (Julian) | Painful constipation with sleeplessness in his late thirties | D (CLM-0006) |
| last year | A urinary stone passed last year after excruciating pain, preceded by headache, heaviness in the head, dizziness and nausea | D (CLM-0008) |
| earlier this year | Severe low mood earlier this year during bitter disputes in his work | D (CLM-0011) |
No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.
| Concern | Status | Evidence |
|---|---|---|
| He is frightened of another attack, especially while preaching or teaching, and of losing the hearing in his left ear | active | S |
| He has felt low and abandoned for weeks and wonders whether the attacks are a spiritual trial rather than an illness | active | S |
| He remembers the pain of the stone last year and wants to avoid another | active | S |
Most recent measures: Hemoglobin [Mass/volume] in Blood 15.1 on 1527-07-28; Leukocytes [#/volume] in Blood by Automated count 9.8 on 1527-08-25; Platelets [#/volume] in Blood by Automated count 238 on 1527-07-28; Sodium [Moles/volume] in Serum or Plasma 137 on 1527-10-27; Potassium [Moles/volume] in Serum or Plasma 3.8 on 1527-10-27; Carbon dioxide, total [Moles/volume] in Serum or Plasma 26 on 1527-07-28; Urea nitrogen [Mass/volume] in Serum or Plasma 15 on 1527-07-28; Creatinine [Mass/volume] in Serum or Plasma 0.98 on 1527-10-27; Glucose [Mass/volume] in Serum or Plasma 92 on 1527-09-22; Calcium [Mass/volume] in Serum or Plasma 9.9 on 1527-10-27; Urate [Mass/volume] in Serum or Plasma 7.4 on 1527-09-22; Thyrotropin [Units/volume] in Serum or Plasma 1.8 on 1527-07-28; Erythrocytes [#/area] in Urine sediment by Microscopy high power field 30 on 1527-08-25; pH of Urine by Test strip 5.5 on 1527-08-25; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1522)/1.73 sq M 98 on 1527-10-27; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 6 on 1527-10-27; Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 9 on 1527-07-28; Cholesterol [Mass/volume] in Serum or Plasma 214 on 1527-09-08; Triglyceride [Mass/volume] in Serum or Plasma 168 on 1527-09-08; Cholesterol in HDL [Mass/volume] in Serum or Plasma 41 on 1527-09-08; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 139 on 1527-09-08; Hemoglobin A1c/Hemoglobin.total in Blood 5.6 on 1527-09-08; Volume of 24 hour Urine 1.6 on 1527-10-27; Calcium [Mass/time] in 24 hour Urine 190 on 1527-10-27; Oxalate [Mass/time] in 24 hour Urine 38 on 1527-10-27; Citrate [Mass/time] in 24 hour Urine 410 on 1527-10-27; Sodium [Moles/time] in 24 hour Urine 140 on 1527-10-27; Urate [Mass/time] in 24 hour Urine 680 on 1527-10-27; Creatinine [Mass/time] in 24 hour Urine 1750 on 1527-10-27 [S]
Strengths and supports: engagement in care [S]
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Recurrent attacks of spinning vertigo for about three months, the worst twelve days ago, lasting hours, with roaring tinnitus, fullness and muffled hearing in the left ear and nausea, the tinnitus persisting between attacks; with low mood, poor sleep and loss of interest; cause not established at intake: an inner-ear disorder suspected, with vestibular migraine, vestibular schwannoma and posterior circulation stroke to be excluded and depression to be assessed; otology consultation requested | resolved | confirmed | R42 | S — Synthetic presenting problem anchored to his documented attacks of April and July 1527; superseded by the diagnoses at the second visit. |
| Ménière disease of the left ear, definite (AAO-HNS 1521 and Bárány Society criteria), with low-frequency sensorineural hearing loss and persistent tinnitus in the left ear; vestibular migraine considered and judged unlikely as the main cause; vestibular schwannoma excluded by MRI | active | confirmed | H81.02 | S — Synthetic modern diagnosis made at the otology consultation, linked to his documented attacks and to the retrospective diagnosis of Ménière disease (R). |
| Major depressive disorder, recurrent, moderate (DSM-5-TR), with low mood, poor sleep, loss of interest, guilt and fatigue for about two months, after earlier periods of spiritual crisis and low mood; no suicidal ideation | active | confirmed | F33.1 | S — Synthetic modern diagnosis linked to his documented Anfechtungen and low periods; not a claim that he was so diagnosed; the retrospective psychiatric readings are disputed (R). |
| Urinary stone disease: one stone passed spontaneously last year after severe pain; stone type and metabolic risk not yet known at intake | active | confirmed | Z87.442 | S — Synthetic modern problem anchored to his documented first stone in 1526. |
| Right distal ureteral stone, 5 mm, at the ureterovesical junction, with mild right hydronephrosis and renal colic; no infection; kidney function normal; managed with naproxen and tamsulosin; passed nine days later; resolved | resolved | confirmed | N20.1 | S — Synthetic acute problem anchored to his documented recurrent stones; this episode is not a historical claim. |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1527-07-28 | Hemoglobin [Mass/volume] in Blood | 15.1 | g/dL | 13.5-17.5 g/dL | Normal | S |
| 1527-07-28 | Leukocytes [#/volume] in Blood by Automated count | 6.8 | 10*3/uL | 4-11 10*3/uL | Normal | S |
| 1527-07-28 | Platelets [#/volume] in Blood by Automated count | 238 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 1527-07-28 | Sodium [Moles/volume] in Serum or Plasma | 140 | mmol/L | 135-145 mmol/L | Normal | S |
| 1527-07-28 | Potassium [Moles/volume] in Serum or Plasma | 4.2 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1527-07-28 | Carbon dioxide, total [Moles/volume] in Serum or Plasma | 26 | mmol/L | 22-29 mmol/L | Normal | S |
| 1527-07-28 | Urea nitrogen [Mass/volume] in Serum or Plasma | 15 | mg/dL | 7-20 mg/dL | Normal | S |
| 1527-07-28 | Creatinine [Mass/volume] in Serum or Plasma | 1.02 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 1527-07-28 | Glucose [Mass/volume] in Serum or Plasma | 94 | mg/dL | 70-99 mg/dL | Normal | S |
| 1527-07-28 | Calcium [Mass/volume] in Serum or Plasma | 9.7 | mg/dL | 8.6-10.3 mg/dL | Normal | S |
| 1527-07-28 | Urate [Mass/volume] in Serum or Plasma | 6.9 | mg/dL | 3.7-8 mg/dL | Normal | S |
| 1527-07-28 | Thyrotropin [Units/volume] in Serum or Plasma | 1.8 | m[IU]/L | 0.45-4.5 mIU/L | Normal | S |
| 1527-07-28 | Erythrocytes [#/area] in Urine sediment by Microscopy high power field | 1 | /[HPF] | 0 to 2 per high-power field | Normal | S |
| 1527-07-28 | pH of Urine by Test strip | 5.5 | [pH] | 5-8 [pH] | Normal | S |
| 1527-07-28 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1522)/1.73 sq M | 94 | mL/min/{1.73_m2} | 60 or more | Normal | S |
| 1527-07-28 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 15 | {score} | S | ||
| 1527-07-28 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 9 | {score} | S | ||
| 1527-08-25 | Leukocytes [#/volume] in Blood by Automated count | 9.8 | 10*3/uL | 4-11 10*3/uL | Normal | S |
| 1527-08-25 | Sodium [Moles/volume] in Serum or Plasma | 137 | mmol/L | 135-145 mmol/L | Normal | S |
| 1527-08-25 | Potassium [Moles/volume] in Serum or Plasma | 3.9 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1527-08-25 | Creatinine [Mass/volume] in Serum or Plasma | 1.12 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 1527-08-25 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1522)/1.73 sq M | 84 | mL/min/{1.73_m2} | 60 or more | Normal | S |
| 1527-08-25 | Glucose [Mass/volume] in Serum or Plasma | 108 | mg/dL | 70-99 mg/dL | High | S |
| 1527-08-25 | Erythrocytes [#/area] in Urine sediment by Microscopy high power field | 30 | /[HPF] | 0 to 2 per high-power field | High | S |
| 1527-08-25 | pH of Urine by Test strip | 5.5 | [pH] | 5-8 [pH] | Normal | S |
| 1527-09-08 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 12 | {score} | S | ||
| 1527-09-08 | Cholesterol [Mass/volume] in Serum or Plasma | 214 | mg/dL | Below 200 | High | S |
| 1527-09-08 | Triglyceride [Mass/volume] in Serum or Plasma | 168 | mg/dL | Below 150 | High | S |
| 1527-09-08 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 41 | mg/dL | 40 or more | Normal | S |
| 1527-09-08 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 139 | mg/dL | Below 130 | High | S |
| 1527-09-08 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.6 | % | Below 5.7 | Normal | S |
| 1527-08-11 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 14 | {score} | S | ||
| 1527-09-22 | Sodium [Moles/volume] in Serum or Plasma | 136 | mmol/L | 135-145 mmol/L | Normal | S |
| 1527-09-22 | Potassium [Moles/volume] in Serum or Plasma | 3.7 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1527-09-22 | Creatinine [Mass/volume] in Serum or Plasma | 1 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 1527-09-22 | Glucose [Mass/volume] in Serum or Plasma | 92 | mg/dL | 70-99 mg/dL | Normal | S |
| 1527-09-22 | Calcium [Mass/volume] in Serum or Plasma | 10 | mg/dL | 8.6-10.3 mg/dL | Normal | S |
| 1527-09-22 | Urate [Mass/volume] in Serum or Plasma | 7.4 | mg/dL | 3.7-8 mg/dL | Normal | S |
| 1527-09-22 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1522)/1.73 sq M | 96 | mL/min/{1.73_m2} | 60 or more | Normal | S |
| 1527-09-22 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 10 | {score} | S | ||
| 1527-10-27 | Sodium [Moles/volume] in Serum or Plasma | 137 | mmol/L | 135-145 mmol/L | Normal | S |
| 1527-10-27 | Potassium [Moles/volume] in Serum or Plasma | 3.8 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1527-10-27 | Creatinine [Mass/volume] in Serum or Plasma | 0.98 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 1527-10-27 | Calcium [Mass/volume] in Serum or Plasma | 9.9 | mg/dL | 8.6-10.3 mg/dL | Normal | S |
| 1527-10-27 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1522)/1.73 sq M | 98 | mL/min/{1.73_m2} | 60 or more | Normal | S |
| 1527-10-27 | Volume of 24 hour Urine | 1.6 | L/(24.h) | 2.5 or more for stone prevention | Low | S |
| 1527-10-27 | Calcium [Mass/time] in 24 hour Urine | 190 | mg/(24.h) | Below 250 in men | Normal | S |
| 1527-10-27 | Oxalate [Mass/time] in 24 hour Urine | 38 | mg/(24.h) | Below 40 | Normal | S |
| 1527-10-27 | Citrate [Mass/time] in 24 hour Urine | 410 | mg/(24.h) | 450 or more | Low | S |
| 1527-10-27 | Sodium [Moles/time] in 24 hour Urine | 140 | mmol/(24.h) | Below 100 for stone prevention | High | S |
| 1527-10-27 | Urate [Mass/time] in 24 hour Urine | 680 | mg/(24.h) | Below 800 in men | Normal | S |
| 1527-10-27 | Creatinine [Mass/time] in 24 hour Urine | 1750 | mg/(24.h) | 1,000 to 2,000 in men; checks completeness | Normal | S |
| 1527-10-27 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 6 | {score} | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1527-07-28 | Body height | 175 | cm | S |
| 1527-07-28 | Body weight | 86 | kg | S |
| 1527-07-28 | Body mass index (BMI) [Ratio] | 28.1 | kg/m2 | S |
| 1527-07-28 | Systolic blood pressure | 128 | mm[Hg] | S |
| 1527-07-28 | Diastolic blood pressure | 82 | mm[Hg] | S |
| 1527-07-28 | Heart rate | 76 | /min | S |
| 1527-07-28 | Respiratory rate | 14 | /min | S |
| 1527-07-28 | Body temperature | 36.7 | Cel | S |
| 1527-07-28 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1527-08-11 | Body height | 175 | cm | S |
| 1527-08-11 | Body weight | 86.2 | kg | S |
| 1527-08-11 | Body mass index (BMI) [Ratio] | 28.1 | kg/m2 | S |
| 1527-08-11 | Systolic blood pressure | 126 | mm[Hg] | S |
| 1527-08-11 | Diastolic blood pressure | 80 | mm[Hg] | S |
| 1527-08-11 | Heart rate | 74 | /min | S |
| 1527-08-11 | Respiratory rate | 14 | /min | S |
| 1527-08-11 | Body temperature | 36.6 | Cel | S |
| 1527-08-11 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1527-09-22 | Body height | 175 | cm | S |
| 1527-09-22 | Body weight | 85.1 | kg | S |
| 1527-09-22 | Body mass index (BMI) [Ratio] | 27.8 | kg/m2 | S |
| 1527-09-22 | Systolic blood pressure | 122 | mm[Hg] | S |
| 1527-09-22 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 1527-09-22 | Heart rate | 72 | /min | S |
| 1527-09-22 | Respiratory rate | 14 | /min | S |
| 1527-09-22 | Body temperature | 36.7 | Cel | S |
| 1527-09-22 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1527-10-27 | Body height | 175 | cm | S |
| 1527-10-27 | Body weight | 84.4 | kg | S |
| 1527-10-27 | Body mass index (BMI) [Ratio] | 27.6 | kg/m2 | S |
| 1527-10-27 | Systolic blood pressure | 120 | mm[Hg] | S |
| 1527-10-27 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 1527-10-27 | Heart rate | 70 | /min | S |
| 1527-10-27 | Respiratory rate | 14 | /min | S |
| 1527-10-27 | Body temperature | 36.6 | Cel | S |
| 1527-10-27 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1527-08-25 | Body height | 175 | cm | S |
| 1527-08-25 | Body weight | 85.8 | kg | S |
| 1527-08-25 | Body mass index (BMI) [Ratio] | 28 | kg/m2 | S |
| 1527-08-25 | Systolic blood pressure | 142 | mm[Hg] | S |
| 1527-08-25 | Diastolic blood pressure | 88 | mm[Hg] | S |
| 1527-08-25 | Heart rate | 96 | /min | S |
| 1527-08-25 | Respiratory rate | 18 | /min | S |
| 1527-08-25 | Body temperature | 36.9 | Cel | S |
| 1527-08-25 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1527-09-08 | Body height | 175 | cm | S |
| 1527-09-08 | Body weight | 85.4 | kg | S |
| 1527-09-08 | Body mass index (BMI) [Ratio] | 27.9 | kg/m2 | S |
| 1527-09-08 | Systolic blood pressure | 124 | mm[Hg] | S |
| 1527-09-08 | Diastolic blood pressure | 80 | mm[Hg] | S |
| 1527-09-08 | Heart rate | 72 | /min | S |
| 1527-09-08 | Respiratory rate | 14 | /min | S |
| 1527-09-08 | Body temperature | 36.6 | Cel | S |
| 1527-09-08 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Purpose | Status | Provenance |
|---|---|---|---|
| 1527-07-28 | New patient visit for attacks of vertigo with left-ear tinnitus and muffled hearing, and low mood: history, neurological and ear examination, blood and urine tests, depression and safety screening, and an otology referral | finished | S |
| 1527-08-11 | Two-week review and otology consultation with audiometry; diagnoses of Ménière disease and recurrent depression | finished | S |
| 1527-09-22 | Six-week review: attacks, MRI result, thiazide and sertraline safety, mood, and the passed stone | finished | S |
| 1527-10-27 | Thirteen-week review: attacks, repeat audiogram, mood, and the 24-hour urine for stone prevention | finished | S |
| 1527-08-25 | Same-day sick visit for right flank pain | finished | S |
| 1527-09-08 | Periodic adult preventive visit | finished | S |
| Intervention | Status | Guideline | Provenance |
|---|---|---|---|
| Otology (neurotology) consultation in two weeks, with audiometry, to confirm the cause of the attacks and plan treatment | completed | GL-AAO-MD-2020 | S |
| Diagnostic work-up at intake: ear and neurological examination, positional testing, blood count, kidney function and electrolytes, calcium, uric acid, TSH and urinalysis; a symptom diary of each attack (start, duration, hearing, tinnitus, ear fullness, headache, light sensitivity); formal audiometry at the otology visit | completed | GL-AAO-MD-2020, GL-BARANY-MD-2015, GL-VM-2022 | S |
| Meclizine only for severe attacks, for no more than three days at a time; sit or lie down at the first warning; no driving, ladders or swimming alone while attacks are active | completed | GL-AAO-MD-2020 | S |
| Depression: PHQ-9 at every visit, a structured diagnostic interview at the next visit, and a safety plan with the 988 Suicide & Crisis Lifeline and the clinic number | completed | GL-CMID-2026, GL-APA-DEP-2019, GL-SUICIDE-2024 | S |
| Stone history: drink enough water to pass at least 2.5 liters of urine a day; serum calcium and uric acid at intake; stone analysis and metabolic testing if another stone occurs | completed | GL-AUA-STONE-2014 | S |
| Ménière disease: education; sodium 1,500 to 2,300 mg a day; caffeine and alcohol limited; hydrochlorothiazide 25 mg daily as maintenance, with sodium and potassium checked at the next visit; no betahistine; MRI of the internal auditory canals with gadolinium; repeat audiogram at about three months; intratympanic steroid held in reserve if disabling attacks continue after three months | completed | GL-AAO-MD-2020, GL-BEMED-2016 | S |
| Recurrent depression: weekly cognitive behavioral therapy with behavioral activation, and sertraline 25 mg daily for a week, then 50 mg, by shared decision; sodium checked on sertraline with the thiazide | completed | GL-APA-DEP-2019, GL-CMID-2026 | S |
| Right ureteral stone: naproxen for pain, tamsulosin as medical expulsive therapy for up to four weeks, urine strained and the stone sent for analysis, and renal ultrasound after passage | completed | GL-AUA-SURG-STONE-2016, GL-AUA-STONE-2014 | S |
| Vestibular rehabilitation for unsteadiness between attacks: a home program taught by a vestibular physical therapist | completed | GL-AAO-MD-2020 | S |
| Stone prevention from the 24-hour urine: fluids to at least 2.5 liters of urine a day, sodium restriction with a dietitian, normal dietary calcium, citrus fruit for citrate, thiazide continued, and a repeat 24-hour urine in about six months | completed | GL-AUA-STONE-2014 | S |
| Goal | Target | Status | Outcome | Provenance |
|---|---|---|---|---|
| Fewer and milder vertigo attacks: no more than one disabling attack a month by three months, and able to preach without fear of an attack | 1527-10-27 | completed | One attack between the second and six-week visits and none in the five weeks before the thirteen-week visit; preaching again | S |
| Depression response (PHQ-9 down by at least 50 percent) by three months | 1527-10-27 | completed | PHQ-9 6 at thirteen weeks, down 60 percent from 15 | S |
| Sodium intake below 2,300 mg a day | 1528-01-31 | active | 24-hour urine sodium 140 mmol (about 3,200 mg) at thirteen weeks: improved but above target | S |
| Urine volume of at least 2.5 liters a day | 1528-01-31 | active | 24-hour urine volume 1.6 liters at thirteen weeks | S |
Structured synthetic safety assessment on 1527-07-28: current ideation absent, intent absent, plan absent. No suicidal ideation, intent, plan or past attempts; during the worst attack he believed he would die but did not wish to. Outpatient care with a safety plan, the 988 Suicide & Crisis Lifeline and the clinic number, and review at every visit [S]